Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

OBJECTIVE: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets. ME...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurol Neurosurg Psychiatry
Asıl Yazarlar: Mochel, Fanny, Hainque, Elodie, Gras, Domitille, Adanyeguh, Isaac M, Caillet, Samantha, Héron, Bénédicte, Roubertie, Agathe, Kaphan, Elsa, Valabregue, Romain, Rinaldi, Daisy, Vuillaumier, Sandrine, Schiffmann, Raphael, Ottolenghi, Chris, Hogrel, Jean-Yves, Servais, Laurent, Roze, Emmanuel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2016
Konular:
Movement Disorders
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853553/
https://ncbi.nlm.nih.gov/pubmed/26536893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311475
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller